Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells
- PMID: 9247567
- DOI: 10.1002/eji.1830270703
Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells
Abstract
The transcription factor NF-kappa B controls the induction of numerous cytokine promoters during the activation of T lymphocytes. Inhibition of T cell activation by the immunosuppressants cyclosporin A (CsA) and FK506 exerts a suppressive effect on the induction of these NF-kappa B-controlled cytokine promoters. We show for human Jurkat T leukemia cells, as well as human and mouse primary T lymphocytes, that this inhibitory effect is accompanied by an impaired nuclear translocation of the Rel proteins c-Rel, RelA/p65 and NF-kappa B1/p50, whereas the nuclear appearance of RelB remains unaffected. CsA does not interfere with the synthesis of Rel proteins, but prevents the inducible degradation of cytosolic NF-kappa B inhibitors I kappa B alpha and I kappa B beta upon T cell activation. CsA neither inhibits the processing of the NF-kappa B1 precursor p105 to p50, nor does it "stabilize" the C-terminal portion of p105, I kappa B gamma, which is degraded during p105 processing to mature p50. These results indicate that CsA interferes with a specific event in the signal-induced degradation of I kappa B alpha and I kappa B beta, but does not affect the processing of NF-kappa B1/p105 to p50.
Similar articles
-
Induction of nuclear factor-kappa B during primary B cell differentiation.J Immunol. 1998 Mar 1;160(5):2308-17. J Immunol. 1998. PMID: 9498771
-
Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.J Immunol. 1993 Apr 1;150(7):2794-804. J Immunol. 1993. PMID: 8454856
-
Differential nuclear localization of p50, p52, and RelB proteins in human accessory cells of the immune response in situ.Eur J Immunol. 1996 Nov;26(11):2547-51. doi: 10.1002/eji.1830261102. Eur J Immunol. 1996. PMID: 8921937
-
Biological and biochemical inhibitors of the NF-kappa B/Rel proteins and cytokine synthesis.Cytokine Growth Factor Rev. 1996 Aug;7(2):175-90. doi: 10.1016/1359-6101(96)00020-2. Cytokine Growth Factor Rev. 1996. PMID: 8899295 Review.
-
RelB, a member of the Rel/NF-kappa B family of transcription factors.Braz J Med Biol Res. 1996 Jul;29(7):895-903. Braz J Med Biol Res. 1996. PMID: 9070378 Review.
Cited by
-
Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells.Antimicrob Agents Chemother. 2001 Jan;45(1):44-7. doi: 10.1128/AAC.45.1.44-47.2001. Antimicrob Agents Chemother. 2001. PMID: 11120942 Free PMC article.
-
Natural anti-inflammatory agents for pain relief.Surg Neurol Int. 2010 Dec 13;1:80. doi: 10.4103/2152-7806.73804. Surg Neurol Int. 2010. PMID: 21206541 Free PMC article.
-
Autoregulation of Th1-mediated inflammation by twist1.J Exp Med. 2008 Aug 4;205(8):1889-901. doi: 10.1084/jem.20072468. Epub 2008 Jul 28. J Exp Med. 2008. PMID: 18663125 Free PMC article.
-
Aplastic anemia in a patient with CVID due to NFKB1 haploinsufficiency.Cold Spring Harb Mol Case Stud. 2020 Dec 17;6(6):a005769. doi: 10.1101/mcs.a005769. Print 2020 Dec. Cold Spring Harb Mol Case Stud. 2020. PMID: 32972988 Free PMC article.
-
Anthracyclines, proteasome activity and multi-drug-resistance.BMC Cancer. 2005 Sep 13;5:114. doi: 10.1186/1471-2407-5-114. BMC Cancer. 2005. PMID: 16159384 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials